A recent prospective German study including 146 pediatric patients demonstrated that pediatric kidney transplant recipients treated with recombinant growth hormone prior to transplant had less anemia than those who were not (p = 0.05) (84). The gene discussed is GH1; the disease is anemia (phenotype).